Evidence map›Paper›PMID 42812750›Full record

ArticlePrecision radiation oncology2026

Xingliang Liu, Gang Wang, Zhenwen Zhao, Haoyu Wang, Hongyu Chen, Xiao Xu, Jingdong Li, Hongjuan Ma

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Precision radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xingliang Liu *Institute of Hepato-Biliary-Pancreatic-Intestinal Disease Affiliated Hospital of North Sichuan Medical College, North Sichuan Medical College Nanchong P. R. China.
Gang Wang *Shanghai Applied Radiation Institute School of Environmental and Chemical Engineering Shanghai University Shanghai P. R. China.
Zhenwen Zhao *Shanghai Applied Radiation Institute School of Environmental and Chemical Engineering Shanghai University Shanghai P. R. China.
Haoyu WangInstitute of Hepato-Biliary-Pancreatic-Intestinal Disease Affiliated Hospital of North Sichuan Medical College, North Sichuan Medical College Nanchong P. R. China.
Hongyu ChenInstitute of Hepato-Biliary-Pancreatic-Intestinal Disease Affiliated Hospital of North Sichuan Medical College, North Sichuan Medical College Nanchong P. R. China.
Xiao XuCancer Center Guangdong Engineering Research Center of Boron Neutron Therapy and Application in Malignant Tumors The Tenth Affiliated Hospital Southern Medical University (Dongguan People's Hospital) Dongguan P. R. China.
Jingdong LiInstitute of Hepato-Biliary-Pancreatic-Intestinal Disease Affiliated Hospital of North Sichuan Medical College, North Sichuan Medical College Nanchong P. R. China.
Hongjuan MaShanghai Applied Radiation Institute School of Environmental and Chemical Engineering Shanghai University Shanghai P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Transarterial radioembolization (TARE) is an important locoregional therapy for hepatocellular carcinoma (HCC). However, clinically used yttrium-90 ( Experimental design: We designed a biodegradable radiometal-chelating microsphere based on amidoxime-functionalized polylactic acid microspheres (PLA-g-PAO-Ms) engineered via electron beam-induced graft polymerization. Results: The PLA-g-PAO-Ms exhibited a high Lu Conclusion: These findings suggest that PLA-g-PAO-Ms provide a biodegradable microsphere system capable of stable radiometal incorporation and effective tumor suppression following intra-arterial administration, offering a promising approach for interventional radionuclide therapy for HCC.

Indexed as

biodegradable microsphereshepatocellular carcinomaradiation‐induced graft polymerizationradiometal chelationtransarterial radioembolization

Identifiers

PMID42812750
PMCPMC13621439

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.